Q4 and FY 2024 Unaudited Trading UpdateLikeFollowShareShare your feedbackQuestions (0)Post questionYour question will be visible to everyone.Start the conversationAsk Shield Therapeutics a question about this update.DiscoverShare your feedbackDiscover
